executive summary
Running head: POC IMMUNOASSAY
Executive Summary: Emergency Department Poc Immunoassay Testing
Lora Atkinson
Grand Canyon University: NURS-451V 10/07/2014
Executive Summary
Introduction
Cardiovascular disease is a substantial concern and has emerged as one of the leading health issues. In examining cardiovascular disease, its incidence is astounding. Each year approximately one million men and women die, averaging one death every thirty three seconds (Heart, 2013).The death rate for cardiovascular issues such as myocardial infarction and CHF claim more lives than cancer and Aids combined. Heart disease will be the number one cause of death by the year 2020 worldwide (Heart, 2013).
Notably heart disease is a significant health problem that not only costs lives but is a significant economic burden with costs related to doctors’ visits, medications, rehabilitation and additional contributors such as loss of work and patient rehabilitations. It is estimated at approximately 485 billion dollars annually can be associated to the treatment of heart related issues such as heart attack and CHF, early diagnosis is imperative (Heart,2013).
The intention of this proposal is to introduce the function of Point of care (POC) testing in the Emergency Department for immunoassay levels and educate on the benefits of early detection of Troponin and Brain naturietic peptide levels which are cardiovascular disease markers. This proposal outlines the purpose, targeted population, costs, and benefits as well as the process of evaluation. Furthermore, acquiring approval of the Emergency Department manager as well as the director is the intention of this proposal and it is hoped that the program once approved can be launched in June of 2015.
Purpose of the Program The purpose of the program is to promote is to acquire funding for the purchase of an immunoassay point of care testing
Executive Summary: Emergency Department Poc Immunoassay Testing
Lora Atkinson
Grand Canyon University: NURS-451V 10/07/2014
Executive Summary
Introduction
Cardiovascular disease is a substantial concern and has emerged as one of the leading health issues. In examining cardiovascular disease, its incidence is astounding. Each year approximately one million men and women die, averaging one death every thirty three seconds (Heart, 2013).The death rate for cardiovascular issues such as myocardial infarction and CHF claim more lives than cancer and Aids combined. Heart disease will be the number one cause of death by the year 2020 worldwide (Heart, 2013).
Notably heart disease is a significant health problem that not only costs lives but is a significant economic burden with costs related to doctors’ visits, medications, rehabilitation and additional contributors such as loss of work and patient rehabilitations. It is estimated at approximately 485 billion dollars annually can be associated to the treatment of heart related issues such as heart attack and CHF, early diagnosis is imperative (Heart,2013).
The intention of this proposal is to introduce the function of Point of care (POC) testing in the Emergency Department for immunoassay levels and educate on the benefits of early detection of Troponin and Brain naturietic peptide levels which are cardiovascular disease markers. This proposal outlines the purpose, targeted population, costs, and benefits as well as the process of evaluation. Furthermore, acquiring approval of the Emergency Department manager as well as the director is the intention of this proposal and it is hoped that the program once approved can be launched in June of 2015.
Purpose of the Program The purpose of the program is to promote is to acquire funding for the purchase of an immunoassay point of care testing
References: Heart Disease and Stroke Statistics--2013. (2013). Journal of the American Heart Association, 127(6), 1-245. Mainor, B., Hardwick, W., & King, W. (January,2002). Evaluation of a Portable Clinical Analyzer in the Pediatric Emergency Department: Analysis of Cost and Turnaround Time. Southern Medical Journal, 95(6), 4-5. Retrieved October 6, 2014. Noyan, T., Gozlukaya, O., & Cankaya, S. (2013). The Evaluation of Cardiac TroponinI Assays Measured Radiometer AQT90 Flex and ReLIA Analyzers. Journal of Medicine and Medical Research, 1(4), 16-22.